30.291  0.431 (1.44%)		04-23 14:39
Open: 30.02 High: 30.66 Volume: 440,458		Pre. Close: 29.86 Low: 29.91 Market Cap: 3,496(M)

Short term
Mid term
Targets	6-month :	37.01	1-year :	38.91
Resists	First :	31.69	Second :	33.31
Pivot price	30.16
Supports	First :	29.05	Second :	24.17
MAs	MA(5) :	29.79	MA(20) :	30.62
	MA(100) :	31.22	MA(250) :	29.86
MACD	MACD :	-0.7	Signal :	-0.7
%K %D	K(14,3) :	27.7	D(3) :	17.2
RSI	RSI(14): 44.5
52-week	High :	36.7	Low :	23.32

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ EVH ] has closed below upper band by 40.4%. Bollinger Bands are 56.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	30.18 - 30.38	30.38 - 30.56
Low:	28.7 - 28.95	28.95 - 29.18
Close:	29.47 - 29.87	29.87 - 30.23

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.

Mon, 22 Apr 2024
In-Depth Examination Of 6 Analyst Recommendations For Evolent Health - Markets Insider

Mon, 08 Apr 2024
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares - Simply Wall St

Sun, 07 Apr 2024
Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134 ... - Yahoo Finance

Tue, 12 Mar 2024
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital - Simply Wall St

Mon, 26 Feb 2024
Here's What Analysts Are Forecasting For Evolent Health, Inc. (NYSE:EVH) After Its Annual Results - Yahoo Finance

Fri, 23 Feb 2024
These Analysts Revise Their Forecasts On Evolent Health After Upbeat Results - Markets Insider

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	114 (M)
Shares Float	109 (M)
Held by Insiders	4.1 (%)
Held by Institutions	112.3 (%)
Shares Short	10,610 (K)
Shares Short P.Month	11,240 (K)

EPS	-1.28
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	9.38
Profit Margin	-5.8 %
Operating Margin	1.2 %
Return on Assets (ttm)	0.8 %
Return on Equity (ttm)	-10.8 %
Qtrly Rev. Growth	45.4 %
Gross Profit (p.s.)	0
Sales Per Share	17.2
EBITDA (p.s.)	1.11
Qtrly Earnings Growth	0 %
Operating Cash Flow	143 (M)
Levered Free Cash Flow	172 (M)

PE Ratio	-23.7
PEG Ratio	0.8
Price to Book value	3.23
Price to Sales	1.76
Price to Cash Flow	24.22

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.